Showing results (1111-1120 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|June 21, 2003
Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary careUlla M Lepola, Henrik Loft, Elin Heldbo ReinesInternational Clinical Psychopharmacology|June 21, 2003
Improving the chance of recovery from the short- and long-term consequences of depressionHans-Jürgen Möller, Koen Demyttenaere, Emilio Sacchetti, et al.International Clinical Psychopharmacology|January 24, 2020
A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorderAndrea Fagiolini, Umberto Albert, Laura Ferrando, et al.International Clinical Psychopharmacology|December 19, 2019
Estimation of lithium clearance in patients with bipolar disorderSaeed Alqahtani, Noha Aljuma'ah, Norah Bin Aydan, et al.International Clinical Psychopharmacology|July 1, 1987
First clinical experience with ifoxetine, a new 5-HT reuptake blocker with particular emphasis on the side-effect profile of the 5-HT-uptake inhibiting drugsA Delini-Stula, R Fischbach, J M Gauthier, et al.International Clinical Psychopharmacology|October 21, 2020
Management of anxiety disorders in children with attention-deficit hyperactivity disorder: a narrative reviewPavel Golubchik, Abraham WeizmanInternational Clinical Psychopharmacology|November 9, 2020
Creatine kinase levels in psychotic patients who use cannabinoidsAmir Fruman, Refael Stryjer, Shira Weizman, et al.International Clinical Psychopharmacology|September 8, 2020
Challenges associated with treating and preventing antipsychotic-induced constipation: considerations and cautions when prescribing novel interventionsTammie Lee Demler, Kelly KriegerInternational Clinical Psychopharmacology|September 8, 2020
Medication utilization among adult patients with attention-deficit/hyperactivity disorder after reimbursement criteria changeEonjeong Kim, Susin Park, Yewon Kim, et al.International Clinical Psychopharmacology|April 1, 1987
The effects of a 50% reduction of cis(z)-flupenthixol decanoate in chronic schizophrenic patients maintained on a high dose regimeI B CooksonPageof 212